Market News & Trends
Major Players in Type 2 Diabetes Shifting Focus to Pricing to Maintain Market Share
The highly mature type 2 diabetes (T2D) market, which is forecast to be valued at $58.7 billion by 2025, will see pharmaceutical companies prioritizing competitive…
Catalent to Commercially Supply Palatin Technologies’ New Bremelanotide FSD Product in Pen Injectors
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it…
Major Players in Type 2 Diabetes Shifting Focus to Pricing to Maintain Market Share
The highly mature type 2 diabetes (T2D) market, which is forecast to be valued at $58.7 billion by 2025, will see pharmaceutical companies prioritizing competitive…
XBiotech Signs Exclusive Licensing Agreement With Megapharm
XBiotech Inc., developer of next-generation True Human antibody therapies, recently announced that it has entered into an exclusive licensing agreement with Megapharm Ltd., to commercialize…
MilliporeSigma to Develop Next-Generation Purification Processes
MilliporeSigma has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.…
Kitov's Lead Drug Achieves Manufacturing Milestone Ahead of Planned NDA Filing With US FDA
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, recently announced that Dexcel Pharma, Kitov's manufacturing partner, has successfully completed an initial stability…
Evonik Acquires Transferra Nanosciences Inc.
Evonik and Transferra Nanosciences, Inc., formerly known as Northern Lipids Inc., recently announced they have signed an asset purchase agreement on June 21, 2016, to…
CordenPharma Caponago Announces Successful Approval of New Sterile Injectable Facility
CordenPharma recently announced the completion and approval of its aseptic filling line in CordenPharma Caponago (IT) by the Italian AIFA for clinical and commercial supply.…
Bio-Path Holdings Announces Collaboration With Thomas Jefferson University
Bio-Path Holdings, Inc. recently announced it has entered into a sponsored research agreement with Thomas Jefferson University to investigate DNAbilize antisense DNA technology for the…
ERT Develops Industry’s First Integration of Continuous Glucose Monitoring Data & eCOA
ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, recently announced a data license agreement with Dexcom to…
Cobra Biologics & Alligator Bioscience Extend Drug Development Partnership
Cobra Biologics has recently been contracted to develop a second cell line for Alligator Bioscience AB. Alligator has requested further support from the team at…
Caladrius Subsidiary, PCT, to Manufacture Phase III Cell Therapy Product for Kiadis Pharma
Caladrius Biosciences, Inc. recently announced that PCT has expanded its relationship with Kiadis Pharma by entering into an agreement for the manufacturing of cell therapy…
Adaptimmune Announces Commercial Development & Supply Agreement
Adaptimmune Therapeutics plc recently announced it has entered into a commercial development and supply agreement with Thermo Fisher Scientific. The new 10-year agreement augments Adaptimmune’s…
Thermo Fisher Scientific & NIBRT Announce Scientific Collaboration
Thermo Fisher Scientific and the National Institute for Bioprocessing Research and Training (NIBRT) recently announced a scientific collaboration focused on the development of analytical solutions…
Pluristem Reports Data Showing PLX-PAD Cells Effective in Treating Duchenne Muscular Dystrophy
Pluristem Therapeutics Inc. recently reported positive data from preclinical studies of its PLX-PAD cells in the treatment of Duchenne muscular dystrophy. The studies were conducted…
Co-Processed Excipients Benefit Market, Offer Opportunity
The excipients market is pharmaceutical manufacturing dependent, and the demand for excipients is constantly changing according to the production needs of manufacturers’ business strategies, marketing…
Hearty CAGRs for Global Cardiac Biomarker Market
The global cardiac biomarker market should see excellent growth rates among major regions due to the growing prevalence and incidence rates of cardiac diseases. BCC…
Co-Processed Excipients Benefit Market, Offer Opportunity
The excipients market is pharmaceutical manufacturing dependent, and the demand for excipients is constantly changing according to the production needs of manufacturers’ business strategies, marketing…
Hearty CAGRs for Global Cardiac Biomarker Market
The global cardiac biomarker market should see excellent growth rates among major regions due to the growing prevalence and incidence rates of cardiac diseases. BCC…
Sekisui XenoTech Introduces New Research BioBank
Sekisui XenoTech Introduces New Research BioBank As part of Sekisui XenoTech’s commitment to furthering knowledge of hepatic diseases, the company has begun providing disease-diagnosed tissue…
